AI-generated summary
The authors developed a catheter with light emitting diodes for near-infrared photoimmunotherapy of bile duct cholangiocarcinoma, testing it in cultured cells and in mice with tumor xenografts. They report that the treatment was effective against cells expressing the targeted receptors, with effect depending on receptor expression level, and that tumor growth was significantly suppressed in treated mice compared with controls (P < .01).
- Who or what was studied
- Cultured cholangiocarcinoma cell lines expressing EGFR or HER2, and mice bearing cholangiocarcinoma xenografts
- Limits stated in the abstract
- The study was conducted in cultured cells and a mouse xenograft model, so the findings are preclinical and their applicability to humans is not established by the abstract.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.